Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20
BW Businessworld

Nepal approves emergency use of Covishield vaccine

Nepal approves emergency use of Covishield vaccine

Photo Credit :

Kathmandu [Nepal], January 15 (ANI): Nepal Government on Friday approved the emergency use of 'Covishield' vaccine, which is being manufactured by the Serum Institute of India (SII).
The decision for the usage of the vaccine was taken by the Department of Drug Administration (DDA).
"It is to notify to all concerned that the conditional permission has been granted for emergency use authorisation of Covishield vaccine against COVID-19 in Nepal as per the departmental decision dated 15th Jan 2021," the DDA said in a notice.
The body had called for vaccine manufacturers to register their products for usage in Nepal on Wednesday, reported The Himalayan Times.
Covishield has been developed by AstraZeneca and Oxford University and will be manufactured by SII.
On Thursday, Ministry of External Affairs (MEA) spokesperson Anurag Srivastava recalled Prime Minister Narendra Modi's statement that India's vaccine production and delivery capacity would be used for the benefit of all humanity in fighting this crisis.
However, he said that it is 'too early to give a specific response' on the Covid-19 vaccine supplies to other countries.
India had earlier given emergency use authorisation to two COVID-19 vaccines Covishield and Covaxin, developed by Bharat Biotech in the country. (ANI)

Disclaimer: The views expressed in the article above are those of the authors' and do not necessarily represent or reflect the views of this publishing house. Unless otherwise noted, the author is writing in his/her personal capacity. They are not intended and should not be thought to represent official ideas, attitudes, or policies of any agency or institution.


ANI

ANI

More From The Author >>